acetazolamide NDC 71335-9729

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-9729Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-9729Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-9729-1	71335972901	180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-9729-1)Marketed from Apr 9, 2026
71335-9729-2	71335972902	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-9729-2)Marketed from Jun 9, 2023
71335-9729-3	71335972903	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-9729-3)Marketed from Apr 9, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): acetazolamide
Generic name (nonproprietary): acetazolamide
Active ingredients: Acetazolamide — 500 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207659
Marketing start: Nov 19, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 71335-9729_5b36deea-8e75-4379-a797-048641a8bf19SPL ID 5b36deea-8e75-4379-a797-048641a8bf19SPL set ID 0d903375-c583-4362-9f8a-f7b74ce01e0bRxCUI 562524UNII O3FX965V0I
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335972901 followed by a unit qualifier and the quantity

Package 71335-9729-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 9, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide extended-release capsules are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207659

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207659
Product	Strength	Form · route	Labeler	Product NDC
acetazolamide	Acetazolamide 500 mg/1	Capsule, Extended releaseOral	Accord Healthcare Inc.	16729-331